FGF2 has been shown to activate the MAPK/ERK pathway in various cancer cells [62], [63], and we show in OVCAR-4 and SKOV-3 cells that ZEB1 expression is MAPK/ERK-dependent. The gene discussed is FGF2; the disease is cancer.